Cargando…
Evaluation of a Gemcitabine‐Doxorubicin‐Paclitaxel Combination Schedule through Flow Cytometry Assessment of Apoptosis Extent Induced in Human Breast Cancer Cell Lines
Combination chemotherapy with gemcitabine (Gem), doxorubicin (Dox), and paclitaxel (Pac) (GAT) has been considered attractive as first‐line treatment in metastatic breast cancer. We compared the potential of various schedules of GAT to induce apoptosis on MDA‐MB–231, MCF7, and T47D human breast canc...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927032/ https://www.ncbi.nlm.nih.gov/pubmed/12036452 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01291.x |